Dow Up 0.48% Nasdaq Up 0.43%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.27 0.02(1.55%) Aug 19, 4:02PM EDT
Prev Close:1.29
Open:1.29
Bid:0.60 x 400
Ask:1.48 x 700
1y Target Est:4.05
Beta:0.92
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.26 - 1.31
52wk Range:1.11 - 3.15
Volume:374,907
Avg Vol (3m):887,558
Market Cap:190.71M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 1.55%190.71M
LLY66.62B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):70.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback